Breyer Capital hired Morgan Cheatham, formerly of Bessemer Venture Partners, as its first healthcare and life sciences partner. This move signals Breyer Capital’s intent to deepen its investments at the intersection of life sciences and AI, targeting early-stage companies that leverage AI in therapeutics, diagnostics, and healthcare services .
Autonomous Insights Today
Autonomous Insights Today © 2024. All Rights Reserved. Powered by DarkDev Studio.


